abstract |
A use of an active ingredient in the manufacture of a medicament, wherein the medicament is used for the treatment of melanoma, and the active ingredient is selected from the group consisting of a compound of formula (I), a pharmaceutically acceptable salt thereof, and a combination thereof , |